Personalized Dendritic-cell-based Vaccines Targeting Cancer Neoantigens
Anticancer Research · 2024-09 · 44 (9) · 3713-3724
DOI: 10.21873/anticanres.17196 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Anticancer Research, online erschienen am 28.08.2024. Verfasst von Takashi Kamigaki und 5 weiteren Autor:innen. Beteiligte Einrichtung: Next Generation Cell and Immunotherapy, Advanced Research Institute for Health Science, Juntendo University, Tokyo, Japan; kamigaki@j-immunother.com. Hauptthemen laut MEDLINE: Dendritic Cells, Cancer Vaccines, Antigens, Neoplasm, Neoplasms. Die Arbeit wurde bisher 23-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Next Generation Cell and Immunotherapy, Advanced Research Institute for Health Science, Juntendo University, Tokyo, Japan; kamigaki@j-immunother.com.
- Seta Clinic Group, Tokyo, Japan.
- Next Generation Cell and Immunotherapy, Advanced Research Institute for Health Science, Juntendo University, Tokyo, Japan.
- LSI Sapporo Clinic, Sapporo, Japan.
Zitieren
APA
Kamigaki, T., Takimoto, R., Okada, S., Ibe, H., Oguma, E., & Goto, S. (2024). Personalized Dendritic-cell-based Vaccines Targeting Cancer Neoantigens. Anticancer Research, 44(9), 3713-3724. https://doi.org/10.21873/anticanres.17196
Vancouver
Kamigaki T, Takimoto R, Okada S, Ibe H, Oguma E, Goto S. Personalized Dendritic-cell-based Vaccines Targeting Cancer Neoantigens. Anticancer Research. 2024;44(9):3713-3724. doi:10.21873/anticanres.17196
BibTeX
@article{Kamigaki2024,
author = {Kamigaki, Takashi and Takimoto, Rishu and Okada, Sachiko and Ibe, Hiroshi and Oguma, Eri and Goto, Shigenori},
title = {Personalized Dendritic-cell-based Vaccines Targeting Cancer Neoantigens},
journal = {Anticancer Research},
year = {2024},
volume = {44},
number = {9},
pages = {3713--3724},
doi = {10.21873/anticanres.17196}
}
EUVIMED